Human medicines European public assessment report (EPAR): Ristfor, sitagliptin,metformin hydrochloride, Date of authorisation: 15/03/2010, Revision: 31, Status: Authorised

EMEA-001489-PIP02-19

EMEA-001489-PIP01-13-M02

EMEA-002821-PIP01-20

Opinion/decision on a Paediatric investigation plan (PIP): Spevigo, spesolimab, decision type: P: decision agreeing on a investigation plan, with or without partial waiver(s) and or deferral(s), therapeutic area: Skin and subcutaneous tissue disorders, PIP number: P/0157/2024

Human medicines European public assessment report (EPAR): Awiqli, insulin icodec, Date of authorisation: 17/05/2024, Revision: 2, Status: Authorised

Meeting of the Executive Steering Group on Shortages and Safety of Medicinal Products (MSSG) – November 2025, Online, European Medicines Agency, Amsterdam, the Netherlands, from 20 November 2025, 10:00 (CET) to 20 November 2025, 12:00 (CET)

Agenda of the HMPC meeting 17-19 November 2025

Medicinal products for human use: monthly figures - October 2025

Human medicines European public assessment report (EPAR): Isentress, raltegravir, Date of authorisation: 19/12/2007, Revision: 45, Status: Authorised